Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP615711.RAb5lFAhKwZyreGZ0ucf-1q0FNYHureaS1Ho7jGss8Oow130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP615711.RAb5lFAhKwZyreGZ0ucf-1q0FNYHureaS1Ho7jGss8Oow130_assertion type Assertion NP615711.RAb5lFAhKwZyreGZ0ucf-1q0FNYHureaS1Ho7jGss8Oow130_head.
- NP615711.RAb5lFAhKwZyreGZ0ucf-1q0FNYHureaS1Ho7jGss8Oow130_assertion description "[Taken together, these results suggest that MUT PI3K imparts a more aggressive phenotype in colon cancer cells and could be a potential therapeutic target for treatment of colon cancer patients bearing PIK3CA mutations.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP615711.RAb5lFAhKwZyreGZ0ucf-1q0FNYHureaS1Ho7jGss8Oow130_provenance.
- NP615711.RAb5lFAhKwZyreGZ0ucf-1q0FNYHureaS1Ho7jGss8Oow130_assertion evidence source_evidence_literature NP615711.RAb5lFAhKwZyreGZ0ucf-1q0FNYHureaS1Ho7jGss8Oow130_provenance.
- NP615711.RAb5lFAhKwZyreGZ0ucf-1q0FNYHureaS1Ho7jGss8Oow130_assertion SIO_000772 17575153 NP615711.RAb5lFAhKwZyreGZ0ucf-1q0FNYHureaS1Ho7jGss8Oow130_provenance.
- NP615711.RAb5lFAhKwZyreGZ0ucf-1q0FNYHureaS1Ho7jGss8Oow130_assertion wasDerivedFrom befree-2016 NP615711.RAb5lFAhKwZyreGZ0ucf-1q0FNYHureaS1Ho7jGss8Oow130_provenance.
- NP615711.RAb5lFAhKwZyreGZ0ucf-1q0FNYHureaS1Ho7jGss8Oow130_assertion wasGeneratedBy ECO_0000203 NP615711.RAb5lFAhKwZyreGZ0ucf-1q0FNYHureaS1Ho7jGss8Oow130_provenance.